Stay updated on PRS-343 HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PRS-343 HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PRS-343 HER2+ Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.6.5 to v3.6.6, signaling a minor platform or rendering update to the page.
    Difference
    0.1%
    Check dated 2026-08-30T17:01:58.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, indicating a minor update or patch to the page's metadata.
    Difference
    0.1%
    Check dated 2026-08-09T07:51:12.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.6.4) replacing the prior version (v3.6.3), indicating a minor update to the site’s backend or documentation.
    Difference
    0.1%
    Check dated 2026-07-25T17:38:51.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.2 to v3.6.3. This indicates a minor backend/content-management update without changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-04T05:13:21.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2. This reflects a backend/template update for the ClinicalTrials.gov study page.
    Difference
    0.1%
    Check dated 2026-06-27T03:06:59.000Z thumbnail image
  9. Check
    87 days ago
    Change Detected
    Summary
    Deleted a large set of keywords and labels that describe the study's target, mechanism, and design (HER2, CD137/4-1BB, PRS-343, dose escalation, expansion cohorts, interventional model, arms and interventions). Related disease context and location references were also removed, reducing the specificity of the trial description.
    Difference
    17%
    Check dated 2026-06-19T22:21:43.000Z thumbnail image

Stay in the know with updates to PRS-343 HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PRS-343 HER2+ Solid Tumors Clinical Trial page.